STAAR Surgical Company (NASDAQ:STAA) is set to issue its quarterly earnings data after the market closes on Wednesday, August 2nd.

STAAR Surgical (NASDAQ:STAA) last posted its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported ($0.05) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.05). The firm had revenue of $20.35 million for the quarter. STAAR Surgical had a negative net margin of 7.53% and a negative return on equity of 10.83%. During the same quarter last year, the business posted ($0.20) EPS. On average, analysts expect STAAR Surgical to post $-0.05 EPS for the current fiscal year and $0.09 EPS for the next fiscal year.

STAAR Surgical Company (NASDAQ:STAA) remained flat at $10.20 during mid-day trading on Thursday. 47,803 shares of the company’s stock traded hands. The firm’s market cap is $417.51 million. The stock’s 50 day moving average is $10.14 and its 200 day moving average is $9.90. STAAR Surgical Company has a 52 week low of $6.51 and a 52 week high of $11.50.

Several research firms have commented on STAA. Canaccord Genuity reiterated a “hold” rating on shares of STAAR Surgical in a research report on Tuesday, July 11th. Zacks Investment Research upgraded shares of STAAR Surgical from a “sell” rating to a “hold” rating in a research report on Wednesday, July 5th.

TRADEMARK VIOLATION WARNING: “STAAR Surgical Company (STAA) Set to Announce Quarterly Earnings on Wednesday” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/07/27/staar-surgical-company-staa-set-to-announce-quarterly-earnings-on-wednesday.html.

About STAAR Surgical

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery.

Earnings History for STAAR Surgical (NASDAQ:STAA)

Receive News & Ratings for STAAR Surgical Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical Company and related companies with MarketBeat.com's FREE daily email newsletter.